--- title: "Apple and Beijing Anzhen Hospital launch a study to monitor atrial fibrillation using Apple Watch" description: "Apple Inc. has partnered with Beijing Anzhen Hospital and the American Heart Association to launch a study using the Apple Watch to monitor the health management of atrial fibrillation patients. The p" type: "news" locale: "en" url: "https://longbridge.com/en/news/261463383.md" published_at: "2025-10-16T13:21:10.000Z" --- # Apple and Beijing Anzhen Hospital launch a study to monitor atrial fibrillation using Apple Watch > Apple Inc. has partnered with Beijing Anzhen Hospital and the American Heart Association to launch a study using the Apple Watch to monitor the health management of atrial fibrillation patients. The project will equip 200 discharged atrial fibrillation patients with heart failure with Apple Watches to observe their assistance in heart failure treatment during a 90-day follow-up period. Cook emphasized that heart disease is a leading cause of death worldwide and expressed optimism about the potential of wearable devices in the treatment of cardiovascular diseases On October 16, Apple CEO Tim Cook announced via Weibo that the company is collaborating with Beijing Anzhen Hospital and the American Heart Association to study the application of the Apple Watch in health management for heart failure patients. The project plans to equip over 200 patients discharged after atrial fibrillation combined with heart failure with Apple Watches. During a 90-day follow-up period, the study will observe whether the Apple Watch aids in the treatment of heart failure. Cook stated that heart disease is the leading cause of death globally and expressed his excitement to work with Beijing Anzhen Hospital and the American Heart Association, leveraging the Apple Watch's advanced machine learning-based atrial fibrillation detection capabilities to conduct research on managing heart failure patients. As the principal investigator, Ma Changsheng, director of the Cardiology Center at Beijing Anzhen Hospital affiliated with Capital Medical University, expressed optimism about the transformative potential of wearable devices in the treatment of cardiovascular diseases ### Related Stocks - [AAPL.US - Apple](https://longbridge.com/en/quote/AAPL.US.md) - [AAPB.US - GraniteShares 2x Long AAPL Daily ETF](https://longbridge.com/en/quote/AAPB.US.md) - [AAPD.US - Direxion Daily AAPL Bear 1x Shares](https://longbridge.com/en/quote/AAPD.US.md) - [AAPU.US - Direxion Daily AAPL Bull 2X Shares](https://longbridge.com/en/quote/AAPU.US.md) - [AAPX.US - T-Rex 2X Long Apple Daily Target ETF](https://longbridge.com/en/quote/AAPX.US.md) - [AAPY.US - Kurv Yield Premium Strategy Apple Aapl ETF](https://longbridge.com/en/quote/AAPY.US.md) - [APLY.US - YieldMax AAPL Option Income Strategy ETF](https://longbridge.com/en/quote/APLY.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 苹果员工证实：iPhone 16e 库存已” 干涸”，17e 发布进入倒计时 | 苹果零售员工反馈 iPhone 16e 库存已基本枯竭，iPad Air 同样面临供货紧张。这一现象通常意味着苹果正在为新品上市腾出渠道空间，预计 iPhone 17e 和 M4 版 iPad Air 将在未来数周内亮相。 | [Link](https://longbridge.com/en/news/275765809.md) | | 苹果将于明天淘汰旧版 HomeKit | 苹果将于 2026 年 2 月 10 日起停止对原始 HomeKit 架构的支持。尚未更新到新 Apple Home 的用户可能会发现他们的智能家居设备在 iPhone、iPad、Mac 或 Apple Watch 上无法使用。此变更特别影 | [Link](https://longbridge.com/en/news/275354363.md) | | 沛嘉医疗申请欧盟批准其心脏植入物 | 沛嘉医疗申请欧盟心脏植入物批准 | [Link](https://longbridge.com/en/news/275249808.md) | | 15:37 ET“喘息型” 心力衰竭患者的新希望：长滩医疗中心协助领导全球首个 HFpEF 设备试验 | 长滩医疗中心的 MemorialCare 心脏与血管研究所正在参与全球 RESPONDER-HF 试验，评估 Corvia®心房分流器在治疗保留射血分数的心力衰竭（HFpEF）中的应用。该创新设备旨在通过降低活动期间的左心房压力来缓解患者的 | [Link](https://longbridge.com/en/news/275654271.md) | | 苹果在第三次审判中成功抵御了 4G 无线专利诉讼 | 苹果成功地对抗了来自 Optis Wireless 的诉讼，该公司指控苹果侵犯其 4G 无线技术专利。此判决是在 Optis 之前在早期审判中赢得了可观的赔偿后作出的，但这些判决后来被推翻。苹果坚持认为这些专利无效，并批评 Optis 的商 | [Link](https://longbridge.com/en/news/275819927.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.